Claims for Patent: 10,485,846

Summary for Patent: 10,485,846

Title:	Collagenase-derived peptides promote tissue regeneration and wound healing
Abstract:	Provided herein are methods and compositions for the treatment of wounds in a mammalian subject. Particularly, novel bioactive polypeptides are provided that promote tissue repair and regeneration, including the activation of/stimulation of wound healing and wound closure, stimulate keratinocyte and endothelial cell motility and/or proliferation.
Inventor(s):	Herman; Ira M. (Boston, MA), Demidova-Rice; Tatiana (Malden, MA)
Assignee:	Tufts University (Medford, MA)
Application Number:	15/534,140
Patent Claims:	1. An isolated peptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO:s 1 and 3-19, wherein the peptide is between 8 and 100 amino acids in length. 2. An isolated peptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO:s 1 and 3-19, wherein the peptide does not comprise a full-length protein. 3. The isolated peptide of claim 2, wherein the peptide comprises not more than 50, 45, 40, 35, 30, 25 or 20 contiguous amino acid residues of the protein from which the peptide was derived. 4. The isolated peptide of claim 1, wherein the peptide consists of an amino acid sequence selected from the group consisting of SEQ ID NO:s 1 and 3-19. 5. A combinatorial peptide comprising an isolated peptide of claim 1 conjugated or fused to a second peptide or polypeptide. 6. A composition or article of manufacture comprising one or more of the isolated peptides of claim 1 and a carrier or excipient. 7. The composition or article of manufacture of claim 6, wherein the carrier or excipient is a pharmaceutically acceptable carrier or excipient. 8. The composition or article of manufacture of claim 6, wherein the one or more of the isolated peptides or one or more of the combinatorial peptides comprise protease cleavage sites, optionally wherein the protease cleavage sites are different in different peptides or combinatorial peptides. 9. The composition or article of manufacture of claim 6, wherein the one or more isolated peptides or one or more combinatorial peptides are anchored to a scaffold, which optionally is a bioerodible and non-immunogenic scaffold. 10. A method to promote wound healing in a subject in need thereof, comprising administering to the subject an effective amount of one or more of the isolated peptides of claim 1. 11. The method of claim 10, wherein the peptide consists of an amino acid sequence selected from the group consisting of SEQ ID NO:s 1 and 3-19. 12. The method of claim 10, wherein the peptide is administered in an amount effective to enhance the rate of migration of keratinocytes or endothelial cells, or a combination of keratinocytes and endothelial cells, towards a wound edge. 13. The method of claim 10, wherein the administration of the peptide results in an increase in the re-epithelialization of the wound. 14. The method of claim 10, wherein the administration of the peptide results in an increase in angiogenesis in or near the wound. 15. The method of claim 10, wherein the peptide is administered at a wound site. 16. The method of claim 10, wherein the wound is a thermal, chronic, acute or surgical wound. 17. The method of claim 10, further comprising administering to the subject a second agent. 18. The method of claim 17, wherein the second agent is a polypeptide. 19. The method of claim 17, wherein the second agent is a growth factor, cytokine, or enzyme. 20. The method of claim 17, wherein the second agent is a non-human collagenase. 21. The method of claim 20, wherein the non-human collagenase is bacterial collagenase. 22. The method of claim 10, wherein the subject is a mammalian subject. 23. The method of claim 22, wherein the mammalian subject is a human.

Details for Patent 10,485,846

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2034-12-12